Cord Blood America, the umbilical cord blood stem cell preservation company announced today that it has signed a Definitive Supplier Agreement with an accredited tissue bank which provides placenta collection services for therapeutic transplantation.

There has been mounting research showing that there are a lot of viable stem cells in the placenta and they can be safely extracted for transplantation. The stem cells can be used to cure chronic blood-related disorders such as sickle cell disease, thalassemia and leukemia, to name just a few.